WOW! Tipperary business secures €18 million in latest funding round
Clonmel-based Shorla Oncology is going from strength to strength
Clonmel, Co Tipperary and Cambridge, Massachusetts-based Shorla Oncology has announced that it has secured $21 million (€18 million) in its latest round of funding.
This recent investment follows a very successful funding round in 2023 and now brings their total fundraising to date to over $60 million.
The Tipperary-business has gone from strength to strength in recent years, with founders Sharon Cunningham and Orlaith Ryan also claiming the prestigious title of overall winners at the EY Entrepreneur of the Year award in 2024.
Shorla Oncology is an Irish-American pharmaceutical company focused on developing treatments for rare cancers, particularly in paediatric oncology.
Founded in 2018, the company is dually headquartered in Clonmel, Co Tipperary and Cambridge, Massachusetts, reflecting its Irish roots and strong US growth trajectory.
Shorla’s mission, delivering new options for patients in areas of oncology long overlooked by big pharma, continues to resonate across both sides of the Atlantic.